A gas chromatography tandem mass spectrometry method for quantification of buprenorphine (BUP) and norbuprenorphine (NBUP) in brain and plasma samples from mice was developed and validated. Analytes were extracted from the brain or plasma by solid phase extraction and quantified within 20 minutes. Calibration was achieved by linear regression with a 1/x weighting factor and d4-buprenorphine internal standard. All products were linear from 1 to 2000 ng/mL with a correlation of determination >0.99. Assay accuracy and precision of back-calculated standards were within ±10%. The lower limit of quantification for both BUP and NBUP from the brain and plasma was 1 ng/mL. This sensitive and specific method can be used for the investigation of BUP mechanism of action and clinical profile.
Keyphrases
- solid phase extraction
- tandem mass spectrometry
- gas chromatography
- gas chromatography mass spectrometry
- high performance liquid chromatography
- ultra high performance liquid chromatography
- molecularly imprinted
- liquid chromatography tandem mass spectrometry
- liquid chromatography
- simultaneous determination
- resting state
- white matter
- high resolution mass spectrometry
- mass spectrometry
- high resolution
- cerebral ischemia
- functional connectivity
- multiple sclerosis
- high throughput
- type diabetes
- subarachnoid hemorrhage
- ms ms
- adipose tissue
- metabolic syndrome
- wild type
- neural network